Prosecution Insights
Last updated: April 19, 2026

Wuhan Jianmin Dapeng Pharmaceutical Co. Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18210068 INTERMEDIATE OF BILIVERDIN, AND PREPARATION METHOD AND USE THEREOF MCDOWELL, BRIAN E 1624 Non-Final OA Jun 14, 2023
18209437 PYRROLINONE COMPOUND AND METHOD FOR PREPARING THE SAME WARD, PAUL V 1622 Non-Final OA Jun 13, 2023
18208862 DIPYRROLIDINE-1-ONE COMPOUNDS AND THEIR PREPARATION METHOD SANCHEZ, JUSTIN CHRISTOPHER 1622 Non-Final OA Jun 12, 2023

Managing Wuhan Jianmin Dapeng Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month